Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis C-Reference-Cited by-同舟云学术

Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis C

Published:2005-08 Issue:8 Volume:5 Page:1909-1913
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Bizollon Thierry,Pradat Pierre,Mabrut Jean-Yves,Chevallier Michelle,Adham Mustapha,Radenne Sylvie,Souquet Jean-Christophe,Ducerf Christian,Baulieux Jacques,Zoulim Fabien,Trepo Christian

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2005.00976.x/fullpdf

Reference24 articles.

1. The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

3. Recurrent and acquired hepatitis C viral infection in liver transplant recipients

4. Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

5. IMPACT OF THE RECURRENCE OF HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION ON THE LONG-TERM VIABILITY OF THE GRAFT1

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications;Experimental and Clinical Transplantation;2021-09

2. Management of Transplant Patients Infected with HCV;Hepatitis C: Care and Treatment;2021

3. Management of HCV Infection After Liver Transplantation;Evidence-based Gastroenterology and Hepatology 4e;2019-02-27

4. Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center;Brazilian Journal of Medical and Biological Research;2019

5. Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review;Revista do Instituto de Medicina Tropical de São Paulo;2019